marijuana stocks

Cara reports 4Q loss

Cara Therapeutics posts loss of $4.2 million in 4th quarter

SHELTON, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a fourth-quarter loss of $4.2 million, after reporting a profit in the same period a year earlier.

The Shelton, Connecticut-based company said it had a loss of 18 cents per share.

The biotechnology company posted revenue of $914,000 in the period.

For the year, the company reported that its loss widened to $17.7 million, or 85 cents per share. Revenue was reported as $3.2 million.

Cara shares have fallen nearly 7 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.30, a drop of 45 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

_____

Keywords: Cara Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

CannaGrow Holdings, Inc. (CGRW) Announces Expansion of Colorado Buffalo Ranch Facility

CannaGrow Holdings Announces Expansion of Colorado Buffalo Ranch Facility CannaGrow Holdings, Inc. (OTC…

MustGrow Biologics Corp. (MGROF) Receives Conditional Approval to Up-List to the TSX Venture Exchange

MustGrow Receives Conditional Approval to Up-List to the TSX Venture Exchange MustGrow…

$NRTI Meets with Scientific/Medical Board To Plan for New CBD-Based Supplement Line

Inergetics’ Scientific/Medical Advisory Board Meets to Discuss Launch Preparations for its New…